# Fulminant Methicillin-Sensitive Staphylococcus aureus Pneumonia in a Steroid-Treated Patient With End-Stage Renal Disease: A Rapidly Fatal Case

**Authors:** Satoshi Yoshizaki, Keiki Shimizu

PMC · DOI: 10.7759/cureus.84155 · 2025-05-15

## TL;DR

A man with kidney disease and on steroids died quickly from a severe staph infection in the lungs, showing how dangerous it can be in vulnerable patients.

## Contribution

Highlights the rapid progression and lethality of MSSA pneumonia in immunocompromised individuals with ESRD.

## Key findings

- MSSA caused rapidly fatal necrotizing pneumonia in a steroid-treated ESRD patient.
- Despite aggressive treatment, the patient died within 28 hours due to multiorgan failure.
- Autopsy confirmed bronchial destruction and alveolar hemorrhage from MSSA infection.

## Abstract

A man in his 50s with end-stage renal disease (ESRD) secondary to gouty nephropathy and on chronic methylprednisolone therapy presented with acute-onset weakness, severe hyperkalemia, metabolic acidosis, and lactic acidemia. Emergency hemodialysis was initiated; however, within hours, he developed respiratory failure and progressive shock. Imaging revealed rapidly evolving right-dominant pneumonia. Despite escalation to broad-spectrum antibiotics, mechanical ventilation, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO), the patient died within 28 hours of admission.

An autopsy revealed fulminant necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus (MSSA), with Gram-positive cocci present in the bronchial lumen and necrotic tissue. Histological findings included bronchial wall destruction, pulmonary edema, and alveolar hemorrhage. Additional findings included bilateral renal atrophy with arteriosclerosis, but no evidence of gouty tophus or urate deposition.

This case illustrates the potential for MSSA to cause rapidly progressive necrotizing pneumonia in immunocompromised hosts. The fulminant nature of the disease emphasizes the importance of early recognition, consideration of toxin-producing strains such as PVL-positive S. aureus, and the initiation of appropriate antimicrobial and supportive therapy. Despite aggressive interventions, the patient succumbed to multiorgan failure, highlighting the lethality of this condition in vulnerable populations.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741)
- **Diseases:** end-stage renal disease (MONDO:0004375), metabolic acidosis (MONDO:0000440), respiratory failure (MONDO:0021113), pneumonia (MONDO:0005249), multiorgan failure (MONDO:0043726)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Diseases:** gouty tophus (MESH:D015210), pulmonary edema (MESH:D011654), lactic acidemia (MESH:D015325), multiorgan failure (MESH:D051437), metabolic acidosis (MESH:D000138), respiratory failure (MESH:D012131), weakness (MESH:D018908), hemorrhage (MESH:D006470), renal atrophy (MESH:D001284), arteriosclerosis (MESH:D001161), gouty nephropathy (MESH:C537696), necrotizing pneumonia (MESH:D000071067), Pneumonia (MESH:D011014), ESRD (MESH:D007676), shock (MESH:D012769), hyperkalemia (MESH:D006947)
- **Chemicals:** Steroid (MESH:D013256), methylprednisolone (MESH:D008775), urate (MESH:D014527), Methicillin (MESH:D008712)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12168823/full.md

---
Source: https://tomesphere.com/paper/PMC12168823